TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
VXRT

Vaxart Inc

Healthcare · Biotechnology

0.449$ -1.1% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement VXRT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -64.2% -62.2% -37.2% -28.8% +137.1% -59.0% -78.0% -88.0% +6,796.3% +288.9% +726.7%
– -93.0% -97.2% +12,255.0% +39.8% -15.8% +36.6% +145.4% -93.3% +37.7% -2.2% –
– +19.3% -56.2% -170.8% – – -260.4% – – +2,590.7% +896.9% +726.7%
– +13.1% +32.8% -53.0% +39.8% -15.8% +36.6% +145.4% +66.3% -15.9% +8.9% +171.6%
– -4.3% -15.2% -53.6% +157.1% -7.4% +145.7% +44.0% +34.2% -23.1% -8.0% -15.3%
– +5.4% +17.5% -99.8% +28,762.7% +7.1% -44.0% +73.4% +360.7% -24.8% +10.2% +130.7%
– – – – – – – – – – – –
– -100.0% – +500.0% +48.9% -10.9% -21.5% -21.0% -11.8% +10.9% +105.2% -4.9%
– – – – – – – – – – – –
– – – -25.0% -63.7% +349.5% -51.4% -55.0% -37.4% +289.6% -0.4% +83.1%
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?